... from the Phase III ExteNET trial were presented at the 2020 Virtual San Antonio Breast Cancer Symposium (SABCS) that is currently taking place.
News
- Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at ...
- Immutep Reports Statistically Significant Survival Benefit for Key Patient Groups in the Ongoing ...
... IMMP) a biotechnology company developing novel immunotherapy treatments for cancer ... These data were selected to be presented in a spotlight presentation at the San Antonio Breast Cancer Symposium 2020, which is being ...
- Puma Biotechnology Presents Updated Results from the Phase II SUMMIT Trial of Neratinib for ...
... trial of neratinib at the 2020 Virtual San Antonio Breast Cancer Symposium ... NERLYNX is a registered trademark of Puma Biotechnology, Inc.
- Johns Hopkins: Census records show founder owned slaves
Nobody asked for her consent, but her cells are widely used in biomedical research. Most Popular. Watch: San Antonio officials stop popular Florida ...
- Feds: Fraudster duped investors with false claims about NASA
James Jeremy Barbera, 64, former chief executive of Nanobeak Biotech Inc., originally called Nanobeak, was released on $1 million bail after ...